These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18795699)

  • 1. Surgically resected hepatocellular carcinomas in patients with non-alcoholic steatohepatitis.
    Maeda T; Hashimoto K; Kihara Y; Ikegami T; Ishida T; Aimitsu S; Fujiwara M
    Hepatogastroenterology; 2008; 55(85):1404-6. PubMed ID: 18795699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma with nonalcoholic steatohepatitis.
    Mori S; Yamasaki T; Sakaida I; Takami T; Sakaguchi E; Kimura T; Kurokawa F; Maeyama S; Okita K
    J Gastroenterol; 2004; 39(4):391-6. PubMed ID: 15168253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y; Hashimoto E; Yatsuji S; Kaneda H; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder.
    Ikeda H; Suzuki M; Takahashi H; Kobayashi M; Okuse N; Moriya H; Koike J; Maeyama S; Yotsuyanagi H; Itoh F
    Pathol Int; 2006 Jan; 56(1):40-5. PubMed ID: 16398679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
    Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
    Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Malik SM; Gupte PA; de Vera ME; Ahmad J
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Miele L; Forgione A; Gasbarrini G; Grieco A
    Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic criteria for non-alcoholic steatohepatitis].
    Hashimoto E
    Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma.
    Bullock RE; Zaitoun AM; Aithal GP; Ryder SD; Beckingham IJ; Lobo DN
    J Hepatol; 2004 Oct; 41(4):685-6. PubMed ID: 15464253
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
    Sorrentino P; D'Angelo S; Ferbo U; Micheli P; Bracigliano A; Vecchione R
    J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary liver cancers with nonalcoholic steatohepatitis.
    Hashizume H; Sato K; Takagi H; Hirokawa T; Kojima A; Sohara N; Kakizaki S; Mochida Y; Shimura T; Sunose Y; Ohwada S; Mori M
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):827-34. PubMed ID: 17873605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis.
    Ichikawa T; Yanagi K; Motoyoshi Y; Hamasaki K; Nakao K; Toriyama K; Eguchi K
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1865-6. PubMed ID: 17074033
    [No Abstract]   [Full Text] [Related]  

  • 13. [Non alcoholic steatohepatitis].
    Manero E; Findor JA; Avagnina A; de Elizalde S; Elsner B
    Medicina (B Aires); 1994; 54(6):625-9. PubMed ID: 7658998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non alcoholic steatohepatitis. Mid-term clinical and histologic course in 10 patients].
    Moreno Sánchez D; Casis Herce B; Martín Algíbez A; Nevado Santos M; Ruiz-Delgado FC; Galvao Filho O; Castellano Tortajada G
    Med Clin (Barc); 1991 May; 96(19):733-6. PubMed ID: 1875751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steatosis and hepatocellular carcinoma risk.
    Smedile A; Bugianesi E
    Eur Rev Med Pharmacol Sci; 2005; 9(5):291-3. PubMed ID: 16231592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.
    Orikasa H; Ohyama R; Tsuka N; Eyden BP; Yamazaki K
    J Submicrosc Cytol Pathol; 2001; 33(1-2):195-200. PubMed ID: 11686402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.
    Takamatsu S; Noguchi N; Kudoh A; Nakamura N; Kawamura T; Teramoto K; Igari T; Arii S
    Hepatogastroenterology; 2008; 55(82-83):609-14. PubMed ID: 18613418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.
    Shimada M; Hashimoto E; Taniai M; Hasegawa K; Okuda H; Hayashi N; Takasaki K; Ludwig J
    J Hepatol; 2002 Jul; 37(1):154-60. PubMed ID: 12076877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NASH and HCC.
    Page JM; Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Imaging of NASH].
    Tanimoto A; Tomita K
    Nihon Rinsho; 2006 Jun; 64(6):1127-32. PubMed ID: 16768120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.